Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings
2024

AI Tool for Early Dementia Prediction

Sample size: 410 publication 10 minutes Evidence: high

Author Information

Author(s): Lee Liz Yuanxi, Vaghari Delshad, Burkhart Michael C., Tino Peter, Montagnese Marcella, Li Zhuoyu, Zühlsdorff Katharina, Giorgio Joseph de, Williams Guy, Chong Eddie, Chen Christopher, Underwood Benjamin R., Rittman Timothy, Kourtzi Zoe

Primary Institution: University of Cambridge

Hypothesis

Can a robust and interpretable predictive model improve early dementia diagnosis and prognosis using non-invasive data?

Conclusion

The predictive model accurately forecasts whether patients with mild cognitive impairment will progress to Alzheimer's disease, outperforming standard clinical markers.

Supporting Evidence

  • The predictive model achieved an accuracy of 81.66% and an AUC of 0.84.
  • It demonstrated sensitivity of 82.38% and specificity of 80.94%.
  • The model was validated against longitudinal clinical outcomes.
  • It reduced misdiagnosis compared to standard clinical markers.
  • The model generalizes well across different memory clinics.
  • It provides a continuous index of cognitive health trajectories.
  • The PPM-derived prognostic index was significantly different across patient groups.
  • The model's predictions were validated against independent real-world data.

Takeaway

Researchers created a smart tool that helps doctors figure out if someone with early memory problems will get worse, using simple tests instead of expensive scans.

Methodology

The study developed a predictive model using cognitive tests and MRI data from multiple centers to assess its ability to predict dementia progression.

Potential Biases

Potential biases may arise from class imbalance in the training data and the representativeness of the cohorts used.

Limitations

The model's generalizability may be limited by the diversity of the training and testing populations and the data collection methods used.

Participant Demographics

Participants included individuals from diverse clinical settings in the UK and Singapore, with varying demographics.

Statistical Information

P-Value

0.01

Confidence Interval

[1.36, 8.60]

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1016/j.eclinm.2024.102725

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication